XV-207

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameXV-207

Drug Alias NameUltra-Long-Acting Tenofovir Prodrug Nanosuspension(Exavir Therapeutics Inc)Tenofovir Prodrug (Exavir Therapeutics Inc)Long-acting prodrug of tenofovir (Exavir Therapeutics Inc)XV-207XV207

ClassificationSmall molecules > ProdrugSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsHepatitis B, ChronicHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesExavir Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesExavir Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsHepatitis B, ChronicHIV Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A